Dr. Christian Fischer to succeed Uwe Röhrhoff as CEO of Gerresheimer AG
Remarkable glass innovation enables enhanced quality parenteral packaging.
An innovative, integrated, passive syringe safety solution, acquired through an exclusive licence from West Pharmaceutical Services, Inc.
Gerresheimer AG expects revenues to recover in the second half of the year.
Dividend increased for sixth time in succession to EUR 1.05 per share.
Dr Christian Fischer will join the Management Board of Gerresheimer AG as an ordinary member on August 1, 2017 before taking over as Chief Executive Officer on September 1, 2017.
Gerresheimer AG brought financial year 2016 to a successful close and sees strong growth prospects for the years ahead.
Gerresheimer AG has announced that it has acquired the majority shareholding in the Indian company Triveni to further accelerate its growth in the emerging markets.
Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG, has informed Dr. Axel Herberg, Chairman of the Supervisory Board of Gerresheimer AG, that after expiry of his contract in February 2018 he ...
Gerresheimer AG has reported strong results in the third quarter, as expected.
Gerresheimer AG performed in accordance with expectations in the second quarter of 2016.
A state-funded Grow NJ grant is designed to encourage Corning Pharmaceutical Glass, a supplier of high-quality glass tubing to the pharmaceutical packaging industry, to invest in its newly acquired...
A dividend of EUR 0.85 per share was approved at the Annual General Meeting of Gerresheimer AG held in Duesseldorf on 28 April.
Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, made a successful start to financial year 2016.
Gerresheimer AG has announced it brought the financial year 2015 to a successful close and sees strong growth prospects for the years ahead.
Gerresheimer AG has successfully wrapped up its refinancing with the launch of a debt issue (Schuldschein) for a total amount of EUR 425m.
Gerresheimer AG sustained its successful trend through the third quarter of the financial year.
Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, will further extend its pharmaceutical packaging business with the acquisition of Centor.
Gerresheimer AG kept up its successful trend in the second quarter of the financial year.
The Annual General Meeting of Gerresheimer AG has approved a dividend of EUR 0.75 per share.